Exercise Intervention for Dense Breast Tissue
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how exercise affects certain markers in the breast tissue and blood of women with dense breast tissue. It focuses on premenopausal women who have been less active and have dense breast tissue, as shown on a recent mammogram. Participants will join a supervised exercise program (Exercise Intervention) and receive support to increase their activity levels. Women who exercise less than 90 minutes per week and can physically handle moderate exercise may be suitable for this trial. As an unphased study, this trial provides a unique opportunity to contribute to research that could enhance health recommendations for women with dense breast tissue.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are on oral contraceptives, you may not be eligible to participate.
What prior data suggests that this exercise intervention is safe for premenopausal women with dense breast tissue?
Research has shown that exercise is generally safe for women, including those with dense breast tissue. Studies have found that aerobic and resistance exercises can enhance overall fitness and health without causing major harm. Participants in these studies did not report any serious side effects.
Moreover, exercise has been linked to a lower risk of breast cancer recurrence and a reduced risk of death in patients. This indicates that regular physical activity is not only safe but also beneficial for long-term health. While this study focuses on exercise for dense breast tissue, existing evidence shows that similar exercise programs are well-tolerated by most people.12345Why are researchers excited about this trial?
Researchers are excited about the exercise intervention for dense breast tissue because it offers a non-invasive, lifestyle-based approach to potentially manage this condition. Unlike current options, which often focus on imaging and surveillance, this treatment emphasizes moderate-intensity aerobic exercise as a proactive strategy. This method not only aims to improve breast tissue density but also promotes overall health through increased physical activity and social support, potentially offering benefits beyond traditional medical treatments.
What evidence suggests that exercise intervention is effective for dense breast tissue?
Research has shown that exercise might help reduce the risk of breast cancer in women with dense breast tissue. This trial will evaluate a specific exercise intervention, consisting of a supervised, moderate-intensity aerobic exercise program. Studies have found that exercise can lead to positive changes in blood and breast tissue, which are indicators of disease. Evidence also suggests that physical activity is linked to lower rates of breast cancer recurrence and fewer deaths from it. Aerobic exercise, in particular, has been connected to changes in breast tissue density, which could be beneficial. Overall, exercise appears promising as a way to manage dense breast tissue.12467
Who Is on the Research Team?
Jennifer Ligibel, MD
Principal Investigator
Dana-Farber Cancer Institute
Are You a Good Fit for This Trial?
This trial is for premenopausal women under 50 with dense breast tissue who don't exercise much (less than 90 minutes of moderate activity per week). They must be able to read English, have no history of breast cancer, and can walk at least two blocks. Women on oral contraceptives or with certain diseases that limit exercise are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a supervised, moderate-intensity aerobic exercise program for 12 weeks
Follow-up
Participants are monitored for changes in breast tissue and blood markers after the exercise intervention
What Are the Treatments Tested in This Trial?
Interventions
- Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dana-Farber Cancer Institute
Lead Sponsor
National Cancer Institute (NCI)
Collaborator